Tone mix
Week by week 52 weeks
Share of BioVie, Inc. Common Stock's 123 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Nov 10, 2025 · tone -100BioVie (NASDAQ:BIVI) Posts Earnings Results, Misses Expectations By $0.19 EPS-91
- Week of Jun 8, 2026 · tone -56Did BioVie Inc. Insiders Breach their Fiduciary Duties to Shareholders?-90
- Week of Dec 15, 2025 · tone +100BioVie advances Parkinson's, long COVID, and liver disease programs ahead of 2026+87
- Week of Mar 17, 2025 · tone +100BioVie (NASDAQ:BIVI) Rating Increased to Strong-Buy at Brookline Capital Management+83
- Week of Sep 7, 2026 · tone +100BioVie (NASDAQ:BIVI) Upgraded at Wall Street Zen+74
- Week of Mar 23, 2026 · tone +94BioVie targets Parkinson's at its source with lead drug bezisterim+65
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about BioVie, Inc. Common Stock in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 5 | 0 |
| Last 30 sessions | 18 | +26 |
| Last 90 sessions | 50 | +27 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Tuesday, October 27, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.proactiveinvestors.com · 1 outletBioVie to present Long COVID trial data at NIH-backed workshopNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| BioVie to present Long COVID trial data at NIH-backed workshop | www.proactiveinvestors.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 26, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.manilatimes.net · 1 outletBioVie Invited to Present Data on Bezisterim in Long COVID at the NIH's RECOVER-TLC Third Annual WorkshopNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| BioVie Invited to Present Data on Bezisterim in Long COVID at the NIH's RECOVER-TLC Third Annual Workshop | www.manilatimes.net | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 22, 2026
1 headline, average tone -100: 0 positive, 0 neutral and 1 negative. Showing all 1.
- www.dailypolitical.com · 1 outletBioVie (NASDAQ:BIVI) Cut to "Sell" at Wall Street ZenNegative
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| BioVie (NASDAQ:BIVI) Cut to "Sell" at Wall Street Zen | www.dailypolitical.com | 1 | Negative |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 21, 2026
2 headlines, average tone +50: 1 positive, 1 neutral and 0 negative. Showing all 2.
- www.proactiveinvestors.com · 1 outletBioVie reports positive Phase 2 Parkinson's data for bezisterimPositive
- www.dailypolitical.com · 1 outletRecent Investment Analysts' Ratings Updates for BioVie (BIVI)Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| BioVie reports positive Phase 2 Parkinson's data for bezisterim | www.proactiveinvestors.com | 1 | Positive |
| Recent Investment Analysts' Ratings Updates for BioVie (BIVI) | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 20, 2026
3 headlines, average tone +58: 2 positive, 1 neutral and 0 negative. Showing all 3.
- www.rttnews.com · 1 outletBioVie's Bezisterim Shows Positive Signals In Long COVID Patients With Greater Symptom BurdenPositive
- www.proactiveinvestors.com · 1 outletBioVie says bezisterim eased fatigue and cognitive symptoms in Long COVID subgroupsPositive
- www.manilatimes.net · 1 outletBioVie Presents Data on Bezisterim in Parkinson's Disease at the 2026 American Neurological Association Annual MeetingNeutral
Show the table · 3 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| BioVie's Bezisterim Shows Positive Signals In Long COVID Patients With Greater Symptom Burden | www.rttnews.com | 1 | Positive |
| BioVie says bezisterim eased fatigue and cognitive symptoms in Long COVID subgroups | www.proactiveinvestors.com | 1 | Positive |
| BioVie Presents Data on Bezisterim in Parkinson's Disease at the 2026 American Neurological Association Annual Meeting | www.manilatimes.net | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about BioVie, Inc. Common Stock, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.